CaseVu
Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects
Independent of revenue growth, these Projects expected to decrease cash burn by 25% in Q3 [...]
Jun
Precipio Shares Growth Catalysts For HemeScreen
Q1 Results and catalysts show promising growth trajectory NEW HAVEN, CT, (May 17th, 2023) – Specialty [...]
May
Precipio Announces Q1-2023 Shareholder Update Call
Conference Call to be held on May 17, 2023 at 5:00 PM EST NEW HAVEN, [...]
May
Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division
Customer’s pathology services annual revenues expected to exceed $1.5M NEW HAVEN, CT, Globenewswire – (May [...]
May
Precipio Signs Another HemeScreen™ Customer
Customer’s revenues expected at $750K at full capacity NEW HAVEN, CT, Globenewswire – (May 4th, [...]
May
Precipio Granted 180-day Extension From NASDAQ To Regain Compliance
Extension will enable the Company to execute on its growth and advance toward breakeven NEW [...]
Apr
Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined
Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022 NEW HAVEN, [...]
Apr
Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call
Conference Call to be held on Monday, April 3rd, 2023 at 5:00 PM EST NEW [...]
Mar
Precipio Ships First IV-Cell® Order to Major US Healthcare System
Products Division revenues begin to diversify beyond HemeScreen® NEW HAVEN, CT, Globenewswire – (March 21st, [...]
Mar
Precipio continues to sign up and onboard HemeScreen™ customers
Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated [...]
Mar